Edwards Lifesciences logo

Edwards Lifesciences

North America, California, United States, Irvine

Description

Edwards Lifesciences is a provider of science of heart valves and hemodynamic monitoring.

Investor Profile

Edwards Lifesciences has made 12 investments, with 2 in the past 12 months and 25% as lead.

Stage Focus

  • Series B (25%)
  • Series C (25%)
  • Series D (8%)
  • Series E (8%)
  • Post Ipo Equity (8%)
  • Series A (8%)
  • Series F (8%)
  • Corporate Round (8%)

Country Focus

  • United States (67%)
  • Israel (17%)
  • France (8%)
  • Singapore (8%)

Industry Focus

  • Health Care
  • Medical Device
  • Biotechnology
  • Medical
  • Architecture
  • Manufacturing
  • Health Diagnostics
  • Pharmaceutical
  • Software
  • Wireless
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Edwards Lifesciences frequently co-invest with?

SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 3
Domain Associates
North America, California, United States, San Diego
Co-Investments: 2
Three Arch Partners
North America, California, United States, Portola Valley
Co-Investments: 2
AV
North America, California, United States, Menlo Park
Co-Investments: 2
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 2
Aperture Venture Partners
North America, New York, United States, New York
Co-Investments: 2
FM
North America, Connecticut, United States, Norwalk
Co-Investments: 2
BioStar Capital
North America, Michigan, United States, Petoskey
Co-Investments: 3
The Vertical Group
North America, New Jersey, United States, Basking Ridge
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2

Which angels does Edwards Lifesciences often collaborate with?

Shared Deals: 1
TJ
North America, California, United States, Mountain View
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Edwards Lifesciences?

Genesis Medtech

Singapore, Central Region, Singapore

Genesis Medtech is a medical device company.

Health CareMedical Device
Corporate RoundAug 19, 2024
Amount Raised: $25,000,000
Affluent Medical

Paris, Ile-de-France, France

Affluent Medical is develops innovative new-generation mini-invasive implants to restore essential physiological functions.

BiotechnologyHealth CareMedical Device
Post Ipo EquityJul 15, 2024
Amount Raised: $9,307,603
Caption Health

Brisbane, California, United States

Caption Health is a medical company that uses artificial intelligence (AI) to interpret ultrasound exams.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMachine LearningMedicalMedical Device
Series BJul 15, 2020
Amount Raised: $53,000,000
V-Wave

Caesarea, Hefa, Israel

V Wave develops an implant for the treatment of congestive heart failure.

BiotechnologyHealth CareMedicalMedical Device
Series CApr 27, 2018
Amount Raised: $70,000,000
Endotronix

Lisle, Illinois, United States

Endotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before.

BiotechnologyHealth CareMedicalMedical DeviceSoftwareWireless
Series CJul 5, 2016
Amount Raised: $37,100,866
V-Wave

Caesarea, Hefa, Israel

V Wave develops an implant for the treatment of congestive heart failure.

BiotechnologyHealth CareMedicalMedical Device
Series BJan 11, 2016
Amount Raised: $28,000,000
CardioKinetix

Menlo Park, California, United States

CardioKinetix is a medical device company offering the Parachutem, a catheter-based treatment for heart failure.

BiotechnologyHealth CareMedical Device
Series FDec 8, 2014
Amount Raised: $50,000,000
Middle Peak Medical

Palo Alto, California, United States

Middle Peak Medical develops and commercializes a novel technology to treat mitral valve disease.

BiotechnologyHealth DiagnosticsPharmaceutical
Series AOct 28, 2013
Amount Raised: $3,000,000
Embrella Cardiovascular

Wayne, Pennsylvania, United States

Embrella Cardiovascular is a medical device company that develops a system to improve embolic cerebral protection.

Health CareMedical Device
Series BOct 1, 2009
Amount Raised: $1,600,000
Vascular Architects

San Jose, California, United States

Vascular Architects are develops and markets devices to treat vascular disease and nonvascular obstructions.

ArchitectureHealth CareManufacturingMedical Device
Series ESep 2, 2004
Amount Raised: $6,600,000